Targeting RBM5 may help disrupt 'undruggable' MYC in childhood leukemia
July 16, 2026
July 16, 2026
MEMPHIS, Tennessee, July 16 [Category: BizHospital] -- St. Jude Children's Research Hospital issued the following news release:
* * *
Targeting RBM5 may help disrupt 'undruggable' MYC in childhood leukemia
*
Scientists from St. Jude Children's Research Hospital and collaborators have identified the RNA-binding protein RBM5 as a potential vulnerability in a set of difficult-to-treat childhood leukemias. They characterized how . . .
* * *
Targeting RBM5 may help disrupt 'undruggable' MYC in childhood leukemia
*
Scientists from St. Jude Children's Research Hospital and collaborators have identified the RNA-binding protein RBM5 as a potential vulnerability in a set of difficult-to-treat childhood leukemias. They characterized how . . .